Entrepreneur Duke Rohlen creates California-based Ajax Health under a new model for innovation and business growth. Calling it the “Chassis and Growth Drivers” model, he structures it to create innovative new products to capture a higher portion of the financial returns. Partnering with major private equity firms, Rohlen considers a $1 billion bid to buy Cordis.
If Ajax’s bid is successful, they will invest an additional $300 million to fund an off-balance sheet accelerator, which will develop innovative new products to drive revenue growth. Should Rohlen and his partners invest the $1.3 billion to implement this model? Is Cordis the right opportunity for Rohlen and his team?
Ajax Health founder Duke Rohlen (HBS MBA 2001) and HBS Professor Regina Herzlinger join host Brian Kenny to discuss the key success factors for both start-up and established medical technology firms. The case “Ajax Health: A New Model for Medical Technology Innovation” showcases how to structure a firm—in any industry—to maximize innovation and financial returns by better aligning incentives for the different skill sets required.
